Using a bigger hammer: the role of stereotactic body radiotherapy in the management of oligometastases

Editorial

Edgar Ben-Josef et al. J Clin Oncol. 2009.

. 2009 Apr 1;27(10):1537-9.

doi: 10.1200/JCO.2008.21.7299. Epub 2009 Mar 2.

No abstract available

Comment on

Phase I study of individualized stereotactic body radiotherapy of liver metastases.
Lee MT, Kim JJ, Dinniwell R, Brierley J, Lockwood G, Wong R, Cummings B, Ringash J, Tse RV, Knox JJ, Dawson LA. Lee MT, et al. J Clin Oncol. 2009 Apr 1;27(10):1585-91. doi: 10.1200/JCO.2008.20.0600. Epub 2009 Mar 2. J Clin Oncol. 2009. PMID: 19255313 Clinical Trial.
Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases.
Rusthoven KE, Kavanagh BD, Burri SH, Chen C, Cardenes H, Chidel MA, Pugh TJ, Kane M, Gaspar LE, Schefter TE. Rusthoven KE, et al. J Clin Oncol. 2009 Apr 1;27(10):1579-84. doi: 10.1200/JCO.2008.19.6386. Epub 2009 Mar 2. J Clin Oncol. 2009. PMID: 19255320 Clinical Trial.
Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.
Rusthoven KE, Kavanagh BD, Cardenes H, Stieber VW, Burri SH, Feigenberg SJ, Chidel MA, Pugh TJ, Franklin W, Kane M, Gaspar LE, Schefter TE. Rusthoven KE, et al. J Clin Oncol. 2009 Apr 1;27(10):1572-8. doi: 10.1200/JCO.2008.19.6329. Epub 2009 Mar 2. J Clin Oncol. 2009. PMID: 19255321 Clinical Trial.